Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma - Poll - MDSpire

Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma

  • By

  • Tim Schlierkamp-Voosen

  • Markus Barden

  • Helena Janning

  • Marcell Kaljanac

  • Dennis Christoph Harrer

  • Celine Dreger

  • Kathrin Hammon

  • Moritz Ertelt

  • Clara T. Schoeder

  • Hólmfridur Rósa Halldórsdóttir

  • Carlos Rodriguez-Pardo

  • Sine Reker Hadrup

  • Simone Thomas

  • Hinrich Abken

  • April 30, 2026

  • 0 min

Share

Original Source(s)

Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma

  • by Tim Schlierkamp-Voosen, Markus Barden, Helena Janning, Marcell Kaljanac, Dennis Christoph Harrer, Celine Dreger, Kathrin Hammon, Moritz Ertelt, Clara T. Schoeder, Hólmfridur Rósa Halldórsdóttir, Carlos Rodriguez-Pardo, Sine Reker Hadrup, Simone Thomas, Hinrich Abken

  • April 30, 2026

Related Content

Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

Delays in Hematology Consultations and Non-Hematology Referrals in Blood Cancer Diagnosis: Insights from a Comprehensive National Survey in Australia

Metabolic Diversity in Tumors Assessed by 18F-FDG PET/CT as a Prognostic Indicator in Diffuse Large B-Cell Lymphoma